Literature DB >> 22306249

Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.

Jing Chen1, Yuan Lin, Ru Zhang, Zhi-jie Huang, Xing-guo Pan.   

Abstract

BACKGROUND AND AIMS: The effects of polymorphism of NAD(P)H quinone oxidoreductase 1 (NQO1 Pro187Ser, rs1800566) on the risks of colorectal adenoma and cancer have been widely studied and results remain controversial. Therefore, the aim of this meta-analysis was to quantitatively assess the relationships.
METHODS: Databases of Medline, Embase and Wanfang were retrieved until May 15, 2011. Pooled odds ratio (OR) and 95% confidence interval (95% CI) as effect sizes were calculated by using fixed- or random-effect model. Cochrane Q-test was used to explore between-study heterogeneity; p <0.10 indicated statistical significance.
RESULTS: A total of 12 case-control studies with 11,700 individuals (including 5528 cases and 6172 controls) were included in this meta-analysis. Of these studies, four studies conducted in Caucasian populations were for colorectal adenoma, and eight studies were for colorectal cancer. NQO1 187Ser allele was significantly associated with increased risk of colorectal adenoma in co-dominant and dominant comparison models (OR = 1.07, 95% CI = 1.04-1.32 for ProSer vs. ProPro and OR = 1.19, 95% CI = 1.06-1.33 for Ser carries vs. ProPro), without between-study heterogeneity. Overall, NQO1 Pro187Ser was not associated with risk of colorectal cancer, without between-study heterogeneity. Subgroup analyses indicated that Ser allele was significantly associated with increased risk of colorectal cancer for Caucasians (OR = 1.14, 95% CI = 1.00-1.30 for ProSer vs. ProPro and OR = 1.16, 95% CI = 1.02-1.31 for Ser carries vs. ProPro).
CONCLUSIONS: This meta-analysis suggested that Ser allele of NQO1 Pro187Ser significantly contributed to the increased risks of colorectal adenoma and cancer in Caucasians.
Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306249     DOI: 10.1016/j.arcmed.2012.01.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

Review 1.  Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.

Authors:  Zahra Montazeri; Evropi Theodoratou; Christine Nyiraneza; Maria Timofeeva; Wanjing Chen; Victoria Svinti; Shanya Sivakumaran; Gillian Gresham; Laura Cubitt; Luis Carvajal-Carmona; Monica M Bertagnolli; Ann G Zauber; Ian Tomlinson; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Julian Little
Journal:  Int J Epidemiol       Date:  2015-10-07       Impact factor: 7.196

Review 2.  NQO1 C609T polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Bo'an Zheng; Zishu Wang; Rui Chai
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

3.  Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.

Authors:  Jolien J M Freriksen; Jody Salomon; Hennie M J Roelofs; Rene H M Te Morsche; Jos W J van der Stappen; Polat Dura; Ben J M Witteman; Martin Lacko; Wilbert H M Peters
Journal:  J Hum Genet       Date:  2014-05-15       Impact factor: 3.172

4.  NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.

Authors:  Christine G Stoehr; Elke Nolte; Sven Wach; Wolf F Wieland; Ferdinand Hofstaedter; Arndt Hartmann; Robert Stoehr
Journal:  Int J Mol Sci       Date:  2012-07-26       Impact factor: 6.208

5.  Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.

Authors:  Qi Zhang; Min Zheng; Xiao-Long Qi; Feng Liu; Zu-Jie Mao; Da-Hong Zhang
Journal:  Onco Targets Ther       Date:  2014-06-05       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.